These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 23068453)

  • 1. Effect of omeprazole on vacuole size in Coxiella burnetii-infected cells.
    Botelho-Nevers E; Singh S; Chiche L; Raoult D
    J Infect; 2013 Mar; 66(3):288-9. PubMed ID: 23068453
    [No Abstract]   [Full Text] [Related]  

  • 2. Biogenesis of the lysosome-derived vacuole containing Coxiella burnetii.
    Kohler LJ; Roy CR
    Microbes Infect; 2015; 17(11-12):766-71. PubMed ID: 26327296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide inhibits Coxiella burnetii replication and parasitophorous vacuole maturation.
    Howe D; Barrows LF; Lindstrom NM; Heinzen RA
    Infect Immun; 2002 Sep; 70(9):5140-7. PubMed ID: 12183564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Q fever.
    Tissot-Dupont H; Raoult D
    Infect Dis Clin North Am; 2008 Sep; 22(3):505-14, ix. PubMed ID: 18755387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxiella burnetii localizes in a Rab7-labeled compartment with autophagic characteristics.
    Berón W; Gutierrez MG; Rabinovitch M; Colombo MI
    Infect Immun; 2002 Oct; 70(10):5816-21. PubMed ID: 12228312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of natural resistance of mouse macrophages to Coxiella burnetii infection in vitro: macrophages from restrictive strains control parasitophorous vacuole maturation.
    Zamboni DS
    Infect Immun; 2004 Apr; 72(4):2395-9. PubMed ID: 15039367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii.
    Rolain JM; Maurin M; Raoult D
    Antimicrob Agents Chemother; 2001 Jan; 45(1):301-2. PubMed ID: 11120982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug activity against Coxiella burnetii, a pathogen of Q fever].
    Tokarevich NK
    Antibiot Khimioter; 2007; 52(1-2):46-56. PubMed ID: 18461810
    [No Abstract]   [Full Text] [Related]  

  • 9. Hydroxychloroquine susceptibility determination of Coxiella burnetii in human embryonic lung (HEL) fibroblast cells.
    Angelakis E; Khalil JB; Le Bideau M; Perreal C; La Scola B; Raoult D
    Int J Antimicrob Agents; 2017 Jul; 50(1):106-109. PubMed ID: 28478211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibility determination for six strains of Coxiella burnetii MST 17 from Cayenne, French Guiana.
    Eldin C; Perreal C; Mahamat A; Djossou F; Edouard S; Raoult D
    Int J Antimicrob Agents; 2015 Nov; 46(5):600-2. PubMed ID: 26391379
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-response model of Coxiella burnetii (Q fever).
    Tamrakar SB; Haluska A; Haas CN; Bartrand TA
    Risk Anal; 2011 Jan; 31(1):120-8. PubMed ID: 20723147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coxiella burnetii stimulates production of RANTES and MCP-1 by mononuclear cells: modulation by adhesion to endothelial cells and its implication in Q fever.
    Meghari S; Desnues B; Capo C; Grau GE; Raoult D; Mege JL
    Eur Cytokine Netw; 2006 Dec; 17(4):253-9. PubMed ID: 17353158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of Coxiella burnetii to azithromycin, doxycycline, ciprofloxacin and a range of newer fluoroquinolones.
    Lever MS; Bewley KR; Dowsett B; Lloyd G
    Int J Antimicrob Agents; 2004 Aug; 24(2):194-6. PubMed ID: 15288324
    [No Abstract]   [Full Text] [Related]  

  • 14. [A comparative study of Coxiella burnetii strains differing in virulence in the intratracheal infection of guinea pigs].
    Suvorova TA; Pshenichnov VA; Grabarev PA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):14-7. PubMed ID: 9245132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular life of Coxiella burnetii in macrophages.
    Ghigo E; Pretat L; Desnues B; Capo C; Raoult D; Mege JL
    Ann N Y Acad Sci; 2009 May; 1166():55-66. PubMed ID: 19538264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Link between impaired maturation of phagosomes and defective Coxiella burnetii killing in patients with chronic Q fever.
    Ghigo E; Honstettre A; Capo C; Gorvel JP; Raoult D; Mege JL
    J Infect Dis; 2004 Nov; 190(10):1767-72. PubMed ID: 15499532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coxiella burnetii inhabits a cholesterol-rich vacuole and influences cellular cholesterol metabolism.
    Howe D; Heinzen RA
    Cell Microbiol; 2006 Mar; 8(3):496-507. PubMed ID: 16469060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in The Netherlands.
    Hogema BM; Slot E; Molier M; Schneeberger PM; Hermans MH; van Hannen EJ; van der Hoek W; Cuijpers HT; Zaaijer HL
    Transfusion; 2012 Jan; 52(1):144-50. PubMed ID: 21756265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication of Coxiella burnetii is inhibited in CHO K-1 cells treated with inhibitors of cholesterol metabolism.
    Howe D; Heinzen RA
    Ann N Y Acad Sci; 2005 Dec; 1063():123-9. PubMed ID: 16481503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure of Q fever pneumonia with moxifloxacin: case report.
    Kuzman I; Puljiz I; Ethaković-Rode O
    Scand J Infect Dis; 2005; 37(10):778-80. PubMed ID: 16191902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.